Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | PNP | P00491 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | POLG | P54098 | 2/20 | 0.33 |
| ▸ | BTN3A1 | O00481 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | POLA1 | P09884 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triphosphate SCHEMBL752824 | 1.00 | FDPS (0.43) | FDPSBLMTDP1PNPPOLB | |
| Triphosphate SCHEMBL29519260 | 1.00 | FDPS (0.43) | FDPSBLMTDP1PNPPOLB | |
| Triphosphate SCHEMBL29575840 | 1.00 | FDPS (0.43) | FDPSBLMTDP1PNPPOLB | |
| Triphosphate SCHEMBL28034540 | 0.98 | FDPS (0.41) | FDPSBLMTDP1PNPPOLB | |
| Triphosphate SCHEMBL4801863 | 0.98 | FDPS (0.41) | FDPSBLMTDP1PNPPOLB | |
| SCHEMBL670322 | 0.98 | FDPS (0.41) | FDPSBLMTDP1PNPPOLB | |
| SCHEMBL28199622 | 0.98 | FDPS (0.41) | FDPSBLMTDP1PNPPOLB | |
| SCHEMBL686905 | 0.98 | FDPS (0.41) | FDPSBLMTDP1PNPPOLB | |
| Pyrophosphoric Acid SCHEMBL3683793 | 0.90 | FDPS (0.56) | FDPSBLMTDP1CYP1A2 | |
| Pyrophosphoric Acid SCHEMBL29167822 | 0.90 | FDPS (0.56) | FDPSBLMTDP1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3487956-B1 | FLAME PROTECTION AGENT MIXTURES, THEIR PREPARATION AND THEIR USE | CLARIANT INT LTD (CH) | 2026-01-14 | — | — | EP | claimed |
| EP-3487957-B1 | FLAME RETARDANT MIXTURES, THE PRODUCTION AND THE USE THEREOF | CLARIANT INT LTD (CH) | 2023-04-12 | — | — | EP | claimed |
| EP-4141059-A1 | DIORGANYLPHOSPHINIC SALTS HAVING EXCEPTIONAL SURFACE STRUCTURE | Clariant International Ltd (CH) | 2023-03-01 | — | — | EP | claimed |
| US-11312910-B2 | Diorganylphosphinic acid salts, method for the production thereof and the use thereof | CLARIANT INTERNATIONAL LTD (CH) | 2022-04-26 | — | — | US | claimed |
| EP-3487861-B1 | DIORGANYLPHOSPHINIC ACID SALTS, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF | CLARIANT INT LTD (CH) | 2021-12-01 | — | — | EP | claimed |
| US-11028324-B2 | Flame retardant mixtures, the production and the use thereof | CLARIANT PLASTICS & COATINGS LTD (CH) | 2021-06-08 | — | — | US | claimed |
| EP-3426731-B1 | HALOGEN-FREE, INTUMESCENT FIRE-PROOF COATING, AND USE THEREOF | CLARIANT INT LTD (CH) | 2021-05-12 | — | — | EP | claimed |
| US-20190316039-A1 | FLAME RETARDANT MIXTURES, THE PRODUCTION AND THE USE THEREOF | CLARIANT PLASTICS & COATINGS LTD (CH) | 2019-10-17 | — | — | US | claimed |
| US-20190292464-A1 | DIORGANYLPHOSPHINIC ACID SALTS, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF | CLARIANT PLASTICS & COATINGS LTD (CH) | 2019-09-26 | — | — | US | claimed |
| EP-3487956-A1 | FLAME PROTECTION AGENT MIXTURES, THEIR PREPARATION AND THEIR USE | Clariant Plastics & Coatings Ltd (CH) | 2019-05-29 | — | — | EP | claimed |
| EP-2141169-A2 | Salts of diorganyl phosphinic acids, method for their manufacture and their application | Clariant Produkte (Deutschland) GmbH (DE) | 2010-01-06 | — | — | EP | claimed |
| EP-2141170-A2 | Salts of diorganyl phosphinic acids, method for their manufacture and their application | Clariant Produkte (Deutschland) GmbH (DE) | 2010-01-06 | — | — | EP | claimed |
| EP-1607400-B1 | Salts of dialkylphosphinic acids, process for their preparation and their use | CLARIANT PRODUKTE DEUTSCHLAND (DE) | 2009-12-02 | — | — | EP | claimed |
| US-7446140-B2 | Dialkylphosphinic salts, their use, and a process for their preparation | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2008-11-04 | — | — | US | claimed |
| US-7420007-B2 | Dialkylphosphinic salts | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2008-09-02 | — | — | US | claimed |
| EP-1544206-B1 | Use of salts of dialkylphosphinic acids | CLARIANT PRODUKTE DEUTSCHLAND (DE) | 2008-03-05 | — | — | EP | claimed |
| US-20060084734-A1 | Dialkylphosphinic salts, their use, and a process for their preparation | CLARIANT GMBH | 2006-04-20 | — | — | US | claimed |
| US-20060074157-A1 | Including the telomers: ethylbutylphospinic salts, butylbutylphosphinic salts, ethylhexylphosphinic salts, butylhexylphosphinic salts, or hexylhexylphosphinic salts; flame-retardant polymer molding materials | CLARIANT GMBH | 2006-04-06 | — | — | US | claimed |
| EP-1607400-A2 | Salts of dialkylphosphinic acids, process for their preparation and their use | Clariant GmbH (DE) | 2005-12-21 | — | — | EP | claimed |
| EP-1544206-A1 | Salts of dialkylphosphinic acids | Clariant GmbH (DE) | 2005-06-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11312910-B2 | Diorganylphosphinic acid salts, method for the production thereof and the use thereof | PPIP5K2, DCPS, FDPS | FDPS 3/4885BLM 4334/4885TDP1 3523/4885 |
| US-20190292464-A1 | DIORGANYLPHOSPHINIC ACID SALTS, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF | PPIP5K2, DCPS, FDPS | FDPS 3/4885BLM 4334/4885TDP1 3523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.